BNET Industries
Last Fiscal Year Sales:$1.9B
- Private
- US
Dow Jones Description
Chiron Corporation, based in Emeryville, CA, deals in human healthcare products, offering blood safety products, vaccines, and a range of therapeutic products. The company offers more than 30 vaccines for flu, meningococcal, and pediatric vaccines. Some of its products are Procleix(R) HIV-1/HCV Assay, RIBA(R) tests, DTP vaccine and Oral polio vaccine, TOBI(R). It develops and markets a range of blood safety products used by blood banks and in transfusions. Founded in 1981, the company has revenue of $1.9 billion and employs about 5,500 people. In April 2006 the company merged with Novartis AG (NYSE:NVS) when Novartis acquired all Chiron shares it didn't already own for $48.00 per share in cash.
President, Vaccines
Daniel B. SolandNumber of Employees 5,500
Contact Information
4560 Horton St
Emeryville, California 94608-2916
(510) 655-8730
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
News & Analysis
Filter by
chiron corp. and patient - All News and Analysis
Chiron Announces Initiation of Phase 1 Trial for CHIR-265 In Melanoma; Clinical Testing of Novel Oncology Compound Begins in Patients with Skin Cancer
EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ:CHIR) today announced the initiation of a Phase 1 clinical trial of CHIR-265, a selective Raf kinase inhibitor, in patients with melanoma.
"Stocks on the Rise".
M2 PRESSWIRE-13 May 2005-WallStreetGrapevine: "Stocks on the Rise"C1994-2005 M2 COMMUNICATIONS LTD RDATE:13052005 Wall Street, NYC -Today, wallstreetgrapevine.com, named; Bio-Matrix Scientific Group Inc. (Pink Sheets: BMXG), Large Scale Biology Corp. (Nasdaq NM: LSBC), Chiron Corporation (Nasdaq NM: CHIR), and Savient Pharmaceuticals...
Health systems in Amarillo, Texas, community share flu vaccine doses.
By George Schwarz, Amarillo Globe-News, Texas Knight Ridder/Tribune Business News Oct. 15--With almost no flu vaccine available in Amarillo, community need and patient safety trumped hospital competition. Officials at Baptist St. Anthony's Health System made about 140 to 150 ...
Chiron Informatics Introduces HIV PromptChart, A Care Management Software Tool; First-in-Class Web-based Software That Enhances Treatment Strategies for HIV Patients
ALAMEDA, Calif.--BW HealthWire--June 29, 1998--Chiron Informatics, a business unit of Chiron Corporation (NASDAQ:CHIR), will introduce HIV PromptChartTM, a care management software tool, at the 12th Annual International AIDS Conference in Geneva.
Chiron and Ciba announce FDA market clearance of Aredia® for treatment of patients with Osteolytic Bone Metastases of breast cancer; First Therapeutic For Osteolytic Bone Metastases Associated with Breast Cancer
EMERYVILLE, Calif. and SUMMIT, N.J.--HealthWire--August 12, 1996-- Chiron Therapeutics, a business unit of Chiron Corporation (Nasdaq: CHIR), and Ciba Pharmaceuticals, a division of Ciba-Geigy Corporation jointly announced today that the United States Food and Drug Administration FDA has cleared ArediaR pamidronate disodium for injection for marketing for the treatment of...
DepoTech commences Phase III trials of DTC 101 in Canada
LA JOLLA, Calif.--BUSINESS WIRE--Nov. 3, 1994--DepoTech Corp. Thursday announced the start of multi-center Canadian Phase III clinical trials for DTC 101, an anti-cancer therapeutic, in patients with neoplastic meningitis. Neoplastic meningitis is a complication of many forms of cancer that occurs when tumors metastasize to the soft-tissue...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Daniel B. Soland | President, Vaccines |
| Gene Walther | President |
| Jack Goldstein | President, Blood Testing |
| William G. Green | President, Blood Testing Division |
| David V. Smith | Chief Financial Officer |
| Meghan B. Leader | CIO & Vice President |
| Rino Rappuoli | Chief Scientific Officer |
| Anne Hill | Vice President, Human Resources |
| Bryan Walser | Vice President |
| Jessica Hoover | Vice President |
| John Lambert | Vice President |
| Kathelyn Steimer | Vice President, Research |
| Leone Patterson | Vice President & Controller |
| Linda Short | Vice President, Corp Resources |
| Ursula B. Bartels | General Counsel & Vice President |
| William (Bill) C. Waller | V.P. of Ethics and Compliance |
| Carlos E Ibanez | |
| David Briscoe | |
| Stephen Emerick | |
| Susan Wilson | |
| Edward E. Penhoet | Director |
| Gilbert F. Amelio | Director |
| J. Richard Fredericks | Director |
| Paul L. Herrling | Director |
| Pierre Douaze | Director |
| Pieter J. Strijkert | Director |
| Raymund Breu | Director |
| Vaughn D. Bryson | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Denise M. O'Leary | Board of Directors |
Daniel Soland has served as Vice President, Chief Commercial Officer of ViroPharma since November 2006. He joined ViroPharma from his previous post as President of Chiron Vaccines. At Chiron, Soland was most recently responsible for managing the vaccine division to annual sales of $1 billion. Prior to Chiron, he was the president and chief executive officer of Epigenesis Pharmaceuticals, a privately held biopharmaceutical company engaged in developing drugs for use in asthma, COPD and allergic rhinitis. Prior to that, Mr. Soland spent nine years with GlaxoSmithKline as the vice president and director of worldwide marketing operations, and five years as their vice president and director of the U.S. vaccines business unit. Mr. Soland holds a Bachelor of Science degree in pharmacy from the University of Iowa, in Iowa City, IA.
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Vaccines | Current |
| ViroPharma Incorporated | Chief Commercial Officer | Current |
| Phillystocks.Com | Vice President, Chief Commercial Officer | Current |
| ViroPharma Incorporated | Vice President | Current |
| Copd | Chief Executive Officer | Former |
| Epigenesis Pharmaceuticals, LLC | Chief Executive Officer | Former |
| Copd | President | Former |
| Epigenesis Pharmaceuticals, LLC | President | Former |
| Chiron | Vice President, Vaccines | Former |
| The University of Iowa | B.S. Degree In Pharmacy | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President | Current |
| Chiron | Vice President, Commercial Development, North America and Asia Pacific | Former |
| Gen-Probe Inc. | Vice President, Global Marketing and International Sales | Former |
| Chiron | Global Head of Diagnostics | Former |
| Michigan State University | B.S. Degree In Microbiology and Immunology | Former |
| Gen-Probe Inc. | Team Member | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Blood Testing | Current |
| Illumina, Inc. | Chairperson | Current |
| Solexa, Inc. | Chairperson | Current |
| Epitope, Inc. | Board of Directors | Current |
| Nanotechnology.Com | Director | Current |
| Bio-IT World, Inc. | Director | Current |
| The Hepatitis C Support Project | Board of Directors | Current |
| OraSure Technologies, Inc. | Board of Directors | Current |
| Histofreezer | Board of Directors | Current |
| Chiron | Board of Directors | Current |
| Applied Imaging Corp. | CEO | Former |
| Applied Imaging Corp. | President | Former |
| Johnson & Johnson | President | Former |
| Chiron | Interim Chief Operating Officer | Former |
| Chiron | Vice President | Former |
| Windamere Venture Partners, LLC | General Partner | Former |
| Chiron | Officer | Former |
| Applied Imaging Corp. | Chairman | Former |
| Immucor, Inc. | Board of Directors | Former |
| St. John's University | Ph.D. In Microbiology | Former |
| St. John's University | M.S. In Immunology | Former |
| Rider University | B.A. In Biology | Former |
| American Home Products Corporation | Team Member | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | President, Blood Testing Division | Current |
| Chiron | Member, Executive Committee | Current |
| Chiron | Senior Vice President | Former |
| Chiron | General Counsel | Former |
| Organization | Position | Status |
|---|---|---|
| Thoratec Corporation | Cfo & Executive Vice President | Current |
| Chiron | Chief Financial Officer | Current |
| Perlegen Sciences, Inc. | Board of Directors | Current |
| Anergen | Chief Financial Officer | Former |
| Anergen | Vice President, Finance | Former |
| Chiron | Vice President | Former |
| Chiron | Controller | Former |
| Chiron | Principal Accounting Officer | Former |
| Golden Gate University | B.A. In Economics and History | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | CIO & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Chief Scientific Officer | Current |
| Chiron | Vice President | Former |
| Chiron | Co-Founder of the Field of Cellular Microbiology | Former |
| Harvard Medical School | Visiting Scientist | Former |
| The Rockefeller University | Visiting Scientist | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Human Resources | Current |
| Baxter International Inc. | Global Vpof Human Resources for the Bioscience Division | Former |
| Baxter International Inc. | Executive | Former |
| University of Wales | Bsc Econ Degree In Industrial Relations | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Chiron | Head of Corporate Business Development | Former |
| Yale Law School | J.D | Former |
| University of California | A.B | Former |
| Chiron | Member of the Law Department | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President | Current |
| Gavi | Representative | Current |
| Acambis plc | Non-Executive Director | Current |
| Cambridge Biostability Limited | Chairman | Current |
| Novavax, Inc. | Chairman | Current |
| aventis Group | Former | |
| Novavax, Inc. | Board of Directors | Current |
| Acambis plc | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Research | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President & Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Vice President, Corp Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | General Counsel & Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | V.P. of Ethics and Compliance | Current |
| Organization | Position | Status |
|---|---|---|
| Novarx Corporation | The Company's Director of Manufacturing | Current |
| Collateral Therapeutics, Inc. | Current | |
| Chiron | Current | |
| Viagene, Inc. | Senior Scientist | Former |
| Viagene, Inc. | Director | Former |
| University of California, San Diego | Ph.D. | Former |
David Briscoe joined Protherics in November 2004 to build Protherics' commercial activities within the EU. He joins the company after spending over 25 years in sales and operational roles, mainly in oncology, with companies such as Chiron, Bristol Myers, Schering Plough and Incyte.
| Organization | Position | Status |
|---|---|---|
| Macromed, Inc. | Director of Marketing and Sales, Europe | Current |
| Incyte Corporation | Current | |
| Chiron | Current | |
| Schering-Plough Corporation | Current |
Stephen Emerick is currently a Corporate GMP Trainer for XOMA (US) LLC in Berkeley, California. He has held training positions in the area of pharmaceutical compliance at DEY LP and Chiron. His areas of expertise include GMPs, ICH Q7A and Quality Systems development. Stephen has over 7 years of industry experience along with 15 years training experience. He is certified as a Training Administrator and a Training Manager by The Training Clinic. Mr. Emerick first began his training career while serving as a Plane Captain in the United States Marine Corps. He possesses a BA in Geology from the University of Colorado.
| Organization | Position | Status |
|---|---|---|
| XOMA Corporation | Corporate Gmp Trainer | Current |
| Biotech Services Training Center (Bstc) | Corporate Gmp Trainer for Xoma (US) | Current |
| Chiron | Current | |
| University of Colorado | Ba In Geology | Former |
| Organization | Position | Status |
|---|---|---|
| Institute for Oneworld Health | Senior Program Director, Diarrheal Disease | Current |
| Dana-Farber Cancer Institute | Current | |
| Chiron | Current | |
| Theravance, Inc. | Project Leader | Former |
| University of Leeds | B.Sc (Hons) Degree In Pharmacology | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Gordon and Betty Moore Foundation | President | Current |
| Renovis, Inc. | Co-Founder | Current |
| Alta Partners | Principal | Current |
| Metabolex, Inc. | Chairman of the Board | Current |
| ZymoGenetics, Inc. | Chairman | Current |
| Chimerix, Inc. | Director | Current |
| Chiron | Director | Current |
| Scynexis, Inc. | Board of Directors | Current |
| Alta Partners | Director | Current |
| ZymoGenetics, Inc. | Board of Directors | Current |
| Gordon and Betty Moore Foundation | Member of the Board of Trustees | Current |
| Chemocentryx, Inc. | Board of Directors | Current |
| Corcept Therapeutics Incorporated | Director | Current |
| National Academy of Sciences | Member | Current |
| Chiron | chief executive officer | Former |
| Chiron | president | Former |
| Chiron | Co-Founder | Former |
| University of California, Berkeley | Member Biochemistry Department | Former |
| University of California, San Diego | Fellow | Former |
| University of California | Dean of the School of Public Health | Former |
| Renovis, Inc. | Chairman of the Board of Directors | Former |
| Chiron | Vice Chairman | Former |
| University of Washington | Ph.D. In Biochemistry | Former |
| Stanford University | A.B. In Biology | Former |
| University of California | post-doctoral fellow | Former |
| Organization | Position | Status |
|---|---|---|
| Jazz Semiconductor, Inc. | CEO | Current |
| Sienna Ventures | Senior Partner | Current |
| Jazz Semiconductor, Inc. | Chairman | Current |
| Thevanguard.Org | Finance Chairman and Systems Strategist | Current |
| Pacific Telesis | Director | Current |
| SBC Communications, Inc. | Board of Directors | Current |
| American Film Institute | Director | Current |
| SBC Communications, Inc. | Director | Current |
| Sematech | Director | Current |
| Bpm Forum | Board of Directors | Current |
| Pacific Summit Capital | Board of Directors | Current |
| Chiron | Director | Current |
| AT&T Inc. | Board of Directors | Current |
| American Film Institute | Trustee | Current |
| Amtech Corp. | Chief Executive Officer | Former |
| Apple Inc. | CEO | Former |
| National Semiconductor Corporation | CEO | Former |
| Rockwell International Corporation | President | Former |
| National Semiconductor Corporation | President | Former |
| Jazz Technologies, Inc. | Co-Founder | Former |
| Jazz Technologies, Inc. | Chairman and CEO | Current |
| Amtech Corp. | Chairman | Former |
| National Semiconductor Corporation | Chairman | Former |
| Jazz Technologies, Inc. | Board of Directors | Former |
| Georgia Institute of Technology | PhD in physics | Former |
| Georgia Institute of Technology | MS | Former |
| Georgia Institute of Technology | BS | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Galenica Ltd. | Board of Directors | Current |
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Crucell N.V. | Board of Directors | Current |
| Crucell N.V. | Chairman | Former |
| University of Utrecht | PhD | Former |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Chiron | Director | Current |
| ICOS Corporation | Director | Current |
| Amylin Pharmaceuticals, Inc. | Director | Current |
| Eli Lilly and Company | CEO | Former |
| Eli Lilly and Company | President | Former |
| Vector Securities International, Inc. | Vice Chairman | Former |
| The University of North Carolina | B.S. Degree In Pharmacy | Former |
| Eli Lilly and Company | member | Former |
Executive News
-
Thoratec Presentation at Baird Conference to be Webcast
Industry Transcripts by Seeking Alpha
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes


